Conversion from cyclosporine to tacrolimus improves quality-of-life indices, renal graft function and cardiovascular risk profile

2004-06-01

Additional Metadata
Keywords	Cardiovascular risk, Cyclosporine, Nephrotoxicity, Renal transplantation, Side-effects, Tacrolimus
Persistent URL	doi.org/10.1111/j.1600-6143.2004.00427.x, hdl.handle.net/1765/66584
Journal	American Journal of Transplantation
Organisation	Department of Internal Medicine
Citation APA APA Style APA-ALL Style AAA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Artz, M., Boots, J., Ligtenberg, G., Roodnat, J., Christiaans, M., Vos, P., Moons, P., Borm, G. F.& Hilbrands, L. (2004). Conversion from cyclosporine to tacrolimus improves quality-of-life indices, renal graft function and cardiovascular risk profile. American Journal of Transplantation, 4(6), 937–945.https://doi.org/10.1111/j.1600-6143.2004.00427.x

Publication